Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ:NUTX).
https://mma.prnewswire.com/media/2395212/Glancy_Prongay.jpg
IF YOU SUFFERED A LOSS ON YOUR NUTEX INVESTMENTS, CLICKHERE BEFORE OCTOBER 21, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT
What Is The Lawsuit About? The complaint filed alleges that, between August 8, 2024 and August 14, 2025, Defendants failed to disclose to investors that: (1) HaloMD was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (2) as a result, to the extent that they were the product of fraudulent conduct, revenuesattributable to the Company's engagement with HaloMD in the IDR process were unsustainable; (3) in addition, the Company overstated the extent to which it had remediated, and/or its ability to remediate, the material weaknesses in its internal controls over financial reporting; (4) as a result, the Company was unable to effectively account for the treatment of certain of its stock based compensation obligations; (5) as a result, Nutex improperly calculated these stock based compensation obligations as equity rather than liabilities; (6) the foregoing increased the risk that the Company would be unable to timely file certain financial reports with the SEC; (7) accordingly, Nutex's business and/or financial prospects were overstated; and (8)as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Contact Us To Participate or Learn More:If you wish tolearn moreabout this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.CharlesLinehan, Esq.,Glancy Prongay & Murray LLP,1925 Century Park East, Suite 2100, Los Angeles California 90067 Email: shareholders@glancylaw.comTelephone: 310-201-9150 (Toll-Free: 888-773-9224) Visit our website atwww.glancylaw.com.Follow us for updates on LinkedIn, Twitter, or Facebook.
If you inquire by email, please include your mailing address, telephone number and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact Us:Glancy Prongay & Murray LLP, 1925 Century Park East, Suite 2100,Los Angeles, CA 90067Charles LinehanEmail: shareholders@glancylaw.comTelephone: 310-201-9150Toll-Free: 888-773-9224 Visit our website at:www.glancylaw.com.
https://edge.prnewswire.com/c/img/favicon.png?sn=LA81474&sd=2025-09-23
View original content to download multimedia:https://www.prnewswire.com/news-releases/nutex-health-inc-nutx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302564925.html
SOURCE Glancy Prongay & Murray LLP
https://rt.newswire.ca/rt.gif?NewsItemId=LA81474&Transmission_Id=202509231809PR_NEWS_USPR_____LA81474&DateId=20250923